Insider Transactions Reported by 20 Insiders of KALA BIO, Inc.

Symbol
KALA on Nasdaq
Location
Arlington, MA

Insiders trading volume in the past year

KALA BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rajeev M. Shah Director $73,564,492 17 Jun 2021
RA CAPITAL MANAGEMENT, L.P. 10%+ Owner $47,446,992 26 May 2022
Gregory Grunberg Director $36,745,536 17 Jun 2021
Hongming Chen Chief Scientific Officer $1,378,431 26 Oct 2021
OXFORD FINANCE LLC 10%+ Owner $1,215,000 25 Nov 2025
BAKER BROS. ADVISORS LP Former 10% owner $588,123 -$1,056,722 -64% 30 Sep 2025
Eric Trachtenberg Chief Legal Officer, Chief Compliance Officer and Secretary $458,765 04 Jan 2024
Mark T. Iwicki Director $212,257 -$137,773 -39% 23 Oct 2025
Mark S. Blumenkranz Director $87,495 11 Jun 2024
Darius Kharabi Chief Business Officer $85,608 -$36,240 -30% 22 Oct 2025
Romulus K. Brazzell Head of Research and Development and Chief Medical Officer $73,701 -$34,846 -32% 22 Oct 2025
Todd Bazemore Director $73,662 -$44,158 -37% 22 Oct 2025
ANDREW I. KOVEN Director $68,566 15 Jun 2025
Howard B. Rosen Director $66,667 15 Jun 2025
Mary Reumuth Chief Financial Officer $59,257 -$38,236 -39% 22 Oct 2025
GREGORY D. PERRY Director $53,909 15 Jun 2025
C. Daniel Myers Director $41,910 15 Jun 2025
Marjan Farid Director $41,377 15 Jun 2025
David E. Lazar Chief Executive Officer, Director $0 18 Dec 2025
Robert Bradley Paull Director 16 Jun 2022

Recent Insider Transactions by Companies or Individuals for KALA BIO, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.